These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7504937)

  • 1. Specificity of antibody-dependent cellular cytotoxicity in sera from human immunodeficiency virus type 2-infected individuals.
    Von Gegerfelt A; Diaz-Pohl C; Fenyö EM; Broliden K
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):883-9. PubMed ID: 7504937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates.
    Ljunggren K; Biberfeld G; Jondal M; Fenyö EM
    J Virol; 1989 Aug; 63(8):3376-81. PubMed ID: 2746734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1.
    Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.
    Vogel T; Kurth R; Norley S
    J Immunol; 1994 Aug; 153(4):1895-904. PubMed ID: 7519220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys.
    von Gegerfelt A; Nilsson C; Putkonen P; Broliden K
    Vaccine; 1994 Oct; 12(13):1203-8. PubMed ID: 7839725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity with SIVmac in east African HIV-1-positive sera: evidence against double infection with HIV-1 and a SIVmac/HIV-2-like virus.
    Blomberg J; Klasse PJ; Pehrson C
    Intervirology; 1990; 31(5):276-84. PubMed ID: 1703133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
    Sherefa K; Sällberg M; Sönnerborg A
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic and immunogenic sites of HIV-2 glycoproteins.
    Chiodi F; Björling E; Samuelsson A; Norrby E
    Chem Immunol; 1993; 56():61-77. PubMed ID: 8452654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection.
    Koup RA; Pikora CA; Mazzara G; Panicali D; Sullivan JL
    Viral Immunol; 1991; 4(4):215-23. PubMed ID: 1726398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.
    de Wolf F; Meloen RH; Bakker M; Barin F; Goudsmit J
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1261-7. PubMed ID: 1710645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.
    Björling E; Broliden K; Bernardi D; Utter G; Thorstensson R; Chiodi F; Norrby E
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6082-6. PubMed ID: 2068087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cross-reactive antigenic target regions for HIV type 1-specific antibody-dependent cellular cytotoxicity.
    Broliden K; Von Gegerfelt A; Persson C; Horal P; Svennerholm B; Wahren B; Björling E; Vahlne A
    AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1699-702. PubMed ID: 8959246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains.
    Ljunggren K; Chiodi F; Biberfeld G; Norrby E; Jondal M; Fenyö EM
    J Immunol; 1988 Jan; 140(2):602-5. PubMed ID: 3335784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cellular cytotoxicity (ADCC) is directed against immunodominant epitopes of the envelope proteins of human immunodeficiency virus 1 (HIV-1).
    Ziegner UH; Frank I; Bernatowicz A; Starr SE; Streckert HJ
    Viral Immunol; 1992; 5(4):273-81. PubMed ID: 1282012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of B-cell antigenic sites on HIV-2 gp125.
    Mannervik M; Putkonen P; Rudén U; Kent KA; Norrby E; Wahren B; Broliden PA
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):177-87. PubMed ID: 1370692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
    Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
    Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.